Pharmaceutical companies, “The next target is the ‘prostatism’ market”
As a target for the next male-specific disease, pharmaceutical companies have focused on ‘prostatism.’
Prostatism, a well-known disease for the middle-aged and aged, is a disease caused as the size of prostate enlarges, creating huge difficulties in everyday life.
Although the main cause of pro...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
